For a complete list of U.S. Food and Drug Administration notices, please visit the FDA’s website for information on all FDA recalls, market withdrawals, and safety alerts.
Click the links below to learn more about the FDA’s latest recalls:
Lupin Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of 2 Lots of Tydemy™ Due to Out of Specification Results at the 12-month Stability Time Point, FDA Published July 31, 2023
Cipla Issues Voluntary Nationwide Recall of Six Batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) Due to Container Defect, FDA published July 7, 2023
The Harvard Drug Group, LLC Issues Voluntary Nationwide Recall of Dronabinol Capsules, USP, 2.5 mg and Ziprasidone Hydrochloride Capsules, 20 mg Due to Label Mix-up, FDA published June 14, 2023
Akorn Issues Voluntary Nationwide Recall of Various Human and Animal Drug Products Within Expiry Due to Company Shutdown, FDA published May 04, 2023